Skip to main content
RKLBFYI

Intelligence Hub

Market analytics and operational performance indicators

Last Updated: 27 minutes ago
Back to Filings
FORM 8-K
AI

Current Report - December 5, 2024

Filed December 5, 2024
·
Period ending December 3, 2024
·
0000950170-24-133686

CEO's family trust exchanges 50.95M common shares for equivalent Preferred Stock.

Brief

Rocket Lab entered an Exchange Agreement with Sir Peter Beck's family trust to swap 50,951,250 common shares for Series A Convertible Participating Preferred Stock on a 1:1 basis. The Preferred Stock preserves equivalent ownership, board influence (min 10% representation), and enables estate planning without dilution. Concurrently, amended CEO employment agreement sets $800K base salary (retro Oct 2024), 100% bonus target, FY24 RSU grants (789,373 total), and FY25 $8M RSUs. Closing expected early 2025 post-HSR.

Detailed Brief

On December 3, 2024, Rocket Lab USA, Inc. signed an Exchange Agreement with The Equatorial Trust (Sir Peter Beck's family trust) to exchange 50,951,250 common shares for the same number of newly created Series A Convertible Participating Preferred Stock. Approved by a Special Committee of independent directors, the transaction aims to retain CEO Beck's leadership and vision, ensuring continuity. Preferred Stock is initially 1:1 convertible, adjustable for splits/dividends, with voting rights as-converted, director designation for at least 10% board seats (initially Beck until 2027 AGM), participating dividends, and minimal liquidation preference. Automatic conversion triggers include Beck's departure, death/disability, or ownership <5%. No redemption by company. Concurrently, Rocket Lab Limited amended Beck's employment agreement: $800K base (retroactive Oct 1, 2024), 100% performance bonus (cash/RSUs), FY24 grants of 631,498 RSUs (quarterly vesting) + 157,875 RSUs (cliff Mar 1, 2025), FY25 $8M RSUs (4-yr quarterly vesting). Termination with 3 months notice; severance per Executive Plan; 24-mo non-compete. Closing subject to HSR antitrust clearance, expected early 2025. Event classified as Contract/Agreement and related_party compensatory arrangement.

Key Telemetry

  • Exchange: 50,951,250 common shares for Series A Preferred Stock (1:1 convertible, no dilution).
  • Preferred rights: Min 10% board seats (Beck initially to 2027), as-converted voting/dividends, auto-convert on Beck departure/<5% ownership.
  • CEO comp: $800K base, 100% bonus, FY24 789,373 RSUs, FY25 $8M RSUs.
  • Closing: Early 2025 post-HSR; approved by Special Committee.
  • Exempt from Securities Act registration under 3(a)(9).

Risk Signals

Related Party
Exchange of 50.95M shares for Preferred Stock with CEO's family trust, preserving significant influence.

Impact Vector

Secures long-term retention of founder-CEO critical for Rocket Lab's Neutron development and launch cadence growth, maintaining strategic vision without equity dilution or cash outlay. Preferred structure locks in influence while aiding estate/tax planning. Near-term: HSR risk minimal; positive signal for stability amid scaling. Investors should view as bullish for leadership continuity; monitor closing and future performance metrics.

Search
Search across missions, customers, news, and SEC filings